Page Nct des essais cliniques
Clinical Trial Results:
RANDOMIZED PHASE II-STUDY ON VALPROIC ACID, ALL-TRANS RETINOIC ACID AND THEIR COMBINATION IN INDUCTION AND CONSOLIDATION THERAPY AS WELL AS PEGFILGRASTIM AFTER CONSOLIDATION THERAPY IN YOUNGER PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
| Summary | |
EudraCT number | 2004-004321-95 |
Trial protocol | AT |
Global completion date | 12 Aug 2011 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 09 Dec 2020 |
First version publication date | 09 Dec 2020 |
Other versions | |
Summary report(s) | AMLSG 07-04 Manuscript2 AMLSG 07-04 Manuscript1 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.